What is CaliPharms, Inc. (KGET)?

CaliPharms, Inc. (KGET) is a stock. View full analysis on Stocks360.

What is the current price of KGET?

The current price of KGET is $0.00. Prices are updated in real time on Stocks360.

What is KGET's price-to-earnings (PE) ratio?

KGET's trailing twelve-month PE ratio is -0.40, based on current price and earnings per share data available on Stocks360.

What is KGET's market capitalization?

KGET's market capitalization is $474,349.00, placing it in the small-cap tier.

CaliPharms, Inc. (KGET)

Stock analysis · OTC

$0.00

Market Cap

$474.35K

PE (TTM)

-0.40

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

N/A

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

680.00

CaliPharms, Inc. (KGET) is a publicly traded company. Latest price: $0.00. Market cap $474.35K. Trailing PE -0.40. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.40×
P/S (TTM)	39.53×
P/B	-0.11×
P/FCF (TTM)	-2.92×
EV / EBITDA	-0.62×
EV / Sales	69.13×
Earnings Yield	-330.05%
Free Cash Flow Yield	-34.20%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$829.61K
Revenue (TTM)	$12.00K
Net Income (TTM)	-$1.57M
Free Cash Flow (TTM)	-$85.56K
Net Debt	$355.26K
Working Capital	-$3.96M
Gross Margin	100.00%
Operating Margin	-11222.67%
Net Margin	-11861.40%
Return on Equity	19.88%
Return on Invested Capital	37.43%